体内CAR-Tin vivo CAR-T
体内重编程T细胞
每条都摘自下方编号的来源原文;只写事实,不写预测或建议。
技术简介
- 传统体外CAR-T需采集患者细胞、在体外改造,再回输患者。1
Marketed CAR-T cell cancer therapies such as Johnson & Johnson’s Carvykti use an “ex vivo” process that involves harvesting a patient’s cells, modifying them and infusing them back into the body.